AHR affected pro-inflammatory cytokines IL-1β, IL-6, IFN-γ, CXCL1, as well as S100β, NGN2, and NGN1 gene and protein expression after MCAO. TMF treatment modulated gene and protein expression related to neurogenesis after stroke, leading an increased proliferation of neural progenitor cells at the ipsilesional neurogenic zones. Here, NEUROG2 is linked to stroke disorder.